Suchergebnisse

Few months after the publication of the monographic section of Annali dell'Istituto Superioredi Sanità second issue of 2014 "Health impact of fibres with fluoro-edenitic composition", the carcinogenicity of fluoro-edenite was assessed by the International Agency for Research on Cancer (IARC) in the frame of Monograph 111. The IARC Working Group concluded that there is sufficient evidence in humans that exposure to fluoroedenite fibrous amphibole causes mesothelioma, and sufficient evidence of carcinogenicity in experimental animals. Fluoro-edenite was allocated to Group 1 (the agent is carcinogenic to humans). Now, in view of the recent IARC evaluation, eventive action in Biancavilla requires an upgrade. First of all, environmental monitoring has to be further implemented. All operations of house cleaning should be performed employing wet tools, in order to avoid dust-raising. It is very important that environmental and biological monitoring be related to epidemiological surveillance. The recently approved act of the Sicilian Government concerning a plan of health interventions in Biancavilla will favour cooperation between national, regional and local health institutions with the common goal of improving the quality and appropriateness of diagnostic and therapeutics procedures offered by the health services.

First published in 1931, this book is the first of three volumes that describe the circumstances of medical work in several European countries at that time. Together, the three books look at public administration, local and national, in relation to the prevention of disease. This first volume focuses on the Dutch, Scandinavian and German speaking countries, as well as Switzerland. It shows that many of these countries have gone beyond most other countries in their in the socialization of medicine in several ways.

This paper on preventive programs for mental disease provides 'an orientation to what we know how to do, what we now hope we are doing, and what we are likely to be doing in the next few years.' Primary prevention (reduction in rate of people becoming diseased) includes such problem areas as general paresis and other organic psychoses, emotional deprivation, parent education, counseling, eugenic sterilization, security (financial, etc.), preventive analysis, and leadership and morale building. There are no programs of secondary prevention (reducing duration of extent of unhealthy states) for psychogenic diseases, but 'we can anticipate that such attempts (prevention of relapses) will be made during the coming years.' The prevention of the consequences of advanced disease and problems of disability and rehabilitation are discussed. D. Wolsk.

Infectious diseases are our business. We have to be vigilant, efficient and effective, because a lot depends on us. European governments understand that as infectious diseases know no borders, there is a constant need for surveillance and assessment of risks to provide a strong and reliable line of defence for all Europeans. Our scientific work is closely linked with that of Health Ministries, national public health institutes, public health researchers, managers and practitioners in every country in Europe, with whom we are in daily contact, exchanging information, providing analysis, guidance and technical support. Protecting Europe from infectious diseases is not a chance benefit. ECDC has been built on well-coordinated public health alert and response systems, rigorous independent scientific evidence and analysis, the capacity to take quick and decisive action and communication expertise to deliver reliable information rapidly to those who need it. All ECDC's central and field operations are organised to support and strengthen these vital public health functions, aiming to add value to country-led responses, particularly in times of financial constraint, and thus help save lives. ECDC is a scientific and technical agency, not a political body. It is our role to let the European Commission, the European Parliament and national health policy-makers have the advice and evidence they need to make decisions and take action to protect health. Working here is very special. Not only because we are on the front line of prevention and control of infectious diseases in Europe, but because of the enthusiasm, diversity and professionalism of our team. ECDC is unique. We are proud to be at the hub of Europe's vast network of dedicated public health specialists, scientists, microbiologists and epidemiologists – over 10 000 in number – who work with us and other partners, like WHO, to protect people from infectious disease threats. We work hard to fine-tune these efforts so as to be worthy of Europe's continued trust and support. With this brochure I invite you to learn more about how we work, what we do and what we offer. ; N/A